HBM N news, videos and press releases
For more news please use our advanced search feature.
HBM N - More news...
HBM N - More news...
- Key Figures 31.01.2025
- HBM Healthcare Investments publishes Quarterly Report as at 31 December 2024 with key figures for the first nine months of the 2024/2025 financial year
- Key Figures 15.01.2025
- HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year
- Key Figures 31.12.2024
- Successful IPO of HBM portfolio company Sai Life Sciences on the Indian stock exchanges NSE and BSE increases NAV per HBM share by 3.2 percent
- Key Figures 15.12.2024
- Marvell Announces Breakthrough Custom HBM Compute Architecture to Optimize Cloud AI Accelerators
- Key Figures 30.11.2024
- Key Figures 15.11.2024
- Key Figures 31.10.2024
- HBM Healthcare Investments publishes Half-Year Report as at 30 September 2024 with key figures for the first six months of the 2024/2025 financial year
- HBM Healthcare Investments publishes Half-Year Report as at 30 September 2024 with key figures for the first six months of the 2024/2025 financial year
- Key Figures 15.10.2024
- HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering
-
HBM Healthcare Investments – executive interview (9 October 2024)
- Key Figures 30.9.2024
- HBM Healthcare Investments posts half-year profit of CHF 23 million for 2024/2025 financial year; currency effects had a strong negative impact on the result
- Key Figures 15.9.2024
- Key Figures 31.8.2024
- Key Figures 15.8.2024
- Key Figures 31.7.2024
- HBM Healthcare Investments publishes Quarterly Report as at 30 June 2024 with key figures for the first three months of the 2024/2025 financial year
- Key Figures 15.7.2024
- Key Figures 30.06.2024
- Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
- Key Figures 15.06.2024
- Key Figures 31.05.2024
- HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
- HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
